Cutting Edge Picks: 3 Med Tech Stocks With Room to Run

InvestorPlace04-30

Med tech stocks could experience a nice growth spurt as they remain at the forefront of medical device innovation. Intuitive Surgical (ISRG): The da Vinci 5 release could help the surgical robot ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2431982613?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-04-30 05:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2431982613","market":"us","top_or_hot":-1,"title":"Cutting Edge Picks: 3 Med Tech Stocks With Room to Run","media":"InvestorPlace","content":"<div>\n<p>Med tech stocks could experience a nice growth spurt as they remain at the forefront of medical device innovation.\nIntuitive Surgical (ISRG): The da Vinci 5 release could help the surgical robot ...</p>\n\n<a href=\"https://investorplace.com/2024/04/cutting-edge-picks-3-med-tech-stocks-with-room-to-run/\">Source Link</a>\n\n</div>\n","source":"investorplace_stock_picks","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cutting Edge Picks: 3 Med Tech Stocks With Room to Run</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCutting Edge Picks: 3 Med Tech Stocks With Room to Run\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-30 05:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2024/04/cutting-edge-picks-3-med-tech-stocks-with-room-to-run/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Med tech stocks could experience a nice growth spurt as they remain at the forefront of medical device innovation.\nIntuitive Surgical (ISRG): The da Vinci 5 release could help the surgical robot ...</p>\n\n<a href=\"https://investorplace.com/2024/04/cutting-edge-picks-3-med-tech-stocks-with-room-to-run/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://investorplace.com/2024/04/cutting-edge-picks-3-med-tech-stocks-with-room-to-run/","article_id":"2431982613","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2431982613","pubTimestamp":1714424862,"sourceInfo":{"source_id":"investorplace_stock_picks","name":"InvestorPlace stock picks"},"weMediaInfo":null,"summary":"The med tech stocks are worth checking out for value investors seeking potentially overlooked growth catalysts.","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","LU0466842654.USD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"A\" (USD) ACC","LU0795875086.SGD":"JPMorgan Investment Funds - Global Income A (div) SGD","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","LU0097036916.USD":"贝莱德美国增长A2 USD","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","LU1032466523.USD":"高盛全球多资产收益组合Acc","LU0882574055.USD":"富达全球健康医疗A ACC","LU1196500208.SGD":"NORDEA STABLE RETURN \"HB\" (SGDHDG) ACC","LU1059921491.USD":"NORDEA 1 GLOBAL STABLE EQUITY \"HB\" (USDHDG) ACC","BK4581":"高盛持仓","BK4504":"桥水持仓","LU1244550221.USD":"FRANKLIN GLOBAL MULTI-ASSET  INCOME \"A\" (USDHEDGED) INC (M)","BK4548":"巴美列捷福持仓","LU1074936037.SGD":"JPMorgan Funds - US Value A (acc) SGD","LU2133065610.SGD":"JPMorgan Investment Funds - Global Dividend A (mth) SGD","JNJ":"强生","LU0795875169.SGD":"JPMorgan Investment Funds - Global Income A (div) SGD-H","LU1244550494.USD":"FRANKLIN GLOBAL MULTI-ASSET INCOME \"A\" (USDHEDGED) ACC","LU2602419157.SGD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"AC\" (SGD) ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU0889566641.SGD":"FTSF - Templeton Shariah Global Equity A Acc SGD","BK4592":"伊斯兰概念","BK4532":"文艺复兴科技持仓","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","ALGN":"艾利科技","LU1032955483.USD":"NORDEA 1 STABLE RETURN \"HB\" (USDHDG) ACC","LU1917777945.USD":"安联专题基金Cl AT Acc","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","LU0079474960.USD":"联博美国增长基金A","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0390134368.USD":"FRANKLIN GLOBAL GROWTH \"A\" (USD) ACC","BK4007":"制药","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","SG9999002224.SGD":"Allianz Global High Payout SGD","LU2023250504.SGD":"Allianz Thematica Cl AMg DIS H2-SGD","BK4082":"医疗保健设备","ISRG":"直觉外科公司","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","LU1221951046.USD":"NORDEA 1 STABLE RETURN \"HM\" (USDHDG) INC","LU1935042991.SGD":"MANULIFE GF GLOBAL MULTI-ASSET DIVERSIFIED INCOME  \"AA\" (SGDHDG) INC","SG9999002232.USD":"Allianz Global High Payout USD","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","LU1221951129.SGD":"NORDEA 1 STABLE RETURN \"HM\" (SGDHDG) INC"},"translate_title":"前沿精选：3只有上涨空间的医疗科技股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALGN":1,"JNJ":1,"ISRG":1},"content_text":"Med tech stocks could experience a nice growth spurt as they remain at the forefront of medical device innovation.\nIntuitive Surgical (ISRG): The da Vinci 5 release could help the surgical robot pioneer gain further from here.\nAlign Technology (ALGN): Management expects 2024 to be a decent growth year as the aligner market steadies from its pandemic-era boom-and-bust days.\nJohnson & Johnson (JNJ): Don’t discount the growth-driving power of the MedTech business, which is full of intriguing candidates.\n\n\n\n\n\n \n\nSource: ArtemisDiana/Shutterstock\n\n\n\nUndoubtedly, investors seem to have a new appetite for next-level revenue growth. Generative AI, GLP-1 weight-loss drugs and other breakthrough innovations (I’m not sure if the metaverse qualifies right now) seek to expand in some pretty massive markets. Some medical technology (med tech) stocks are capable of impressive growth as they aim to improve the lives of those with specific issues. \nWith many top medical tech and device firms trading at reasonable prices, investors may wish to give them a closer look as the tech market grows increasingly choppy.\nLet’s examine three med tech stocks that are slightly undervalued relative to their impressive product portfolios and innovative pipelines that may be able to drive solid share price appreciation over the coming years.\nIntuitive Surgical (ISRG)\nSource: Sundry Photography / Shutterstock.comIntuitive Surgical (NASDAQ:ISRG) is a $132 billion med tech titan innovating on surgical robotics’s cutting edge. The company recently took a slight breather, falling almost 7% after briefly breaching all-time highs of over $400 per share.\nWith the number of da Vinci surgeries bouncing back in China, the company may have the tailwind it needs to push to even higher highs as it rides on the back of its international expansion while putting the finishing touches on its recently cleared fifth-generation robot.\nThe stock has had a rather turbulent ride since it bottomed in the back half of 2022. Though demand for new surgical robots is bound to be quite cyclical, new innovations (think new generations of da Vinci) have the potential to power explosive growth. After all, it’s hard for an operator not to upgrade to the best equipment if there’s a chance of improving patient outcomes.\nUp ahead, the da Vinci 5 model, which betters the previous version across many metrics (think increased precision, better force sensing and more processing power), could act as a big growth driver for the firm. Indeed, it’s quite an exciting time to own INTU stock, which is going for a very reasonable 67.2 times trailing price-to-earnings (P/E).\nAlign Technology (ALGN)\nSource: rafapress / Shutterstock.comAlign Technology (NASDAQ:ALGN) is an underrated med tech firm stuck in a massive rut. Shares collapsed in 2021 and 2022 as the pandemic-fuelled boom eventually went bust. Undoubtedly, the perfect time to get one’s teeth straightened was during lockdown.\nDemand is normalizing while the company innovates with new aligner products. ALGN stock is a worthy dental tech play. It looks to add to the newfound momentum it’s enjoyed since November 2023.\nThe company also expects decent growth in 2024, calling for revenue to rise by 6-8% as price hikes look to kick in. At writing, the stock trades for 35.7 times forward P/E. It isn’r a cheap stock, but with such a dominant lead in its market that further innovations could widen, I’d not sleep on the name as it comes in again.\nJohnson & Johnson (JNJ)\nSource: Alexander Tolstykh / Shutterstock.comJohnson & Johnson (NYSE:JNJ) stock has been a perennial underperformer in recent years, with shares now trading at four-year lows of around $146 and change. The talc powder controversy has been a thorn in the firm’s side for quite some time.\nThe firm shoots to return to the growth track with its medtech and medicine businesses. It may be worthwhile picking up a few shares of the $358 billion behemoth as many investors tire of waiting for JNJ stock to turn a corner.\nThe company has ambitious plans to expand medtech from here. A fully loaded pipeline of impressive devices (particularly in interventional cardiovascular) may help the firm jolt sales growth and stock. For now, though, average investors, who likely view the behemoth as a firm whose best growth days are long behind them, won’t appreciate the medtech pipeline.\nAt writing, JNJ stock trades at a reasonable 20.0 times trailing P/E. The 3.34% dividend yield is also a nice bonus.\nOn the date of publication, Joey Frenette did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.\nJoey Frenette is a seasoned investment writer specializing in technology and consumer stocks. Contributing to the Motley Fool Canada, TipRanks, and Barchart, Joey excels in spotting mispriced stocks with long-term growth potential in a fast-paced market.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nSubmit\n\n\n\n\n\n\n\nArticle printed from InvestorPlace Media, https://investorplace.com/2024/04/cutting-edge-picks-3-med-tech-stocks-with-room-to-run/.\n©2024 InvestorPlace Media, LLC","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2431982613"}